These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37244361)

  • 1. One size does not fit all: PMRT in ypN0 HER-2 positive breast cancer.
    Saifi O; Zeidan YH
    Radiother Oncol; 2023 Aug; 185():109725. PubMed ID: 37244361
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials.
    Saifi O; Bachir B; Panoff J; Poortmans P; Zeidan YH
    Radiother Oncol; 2023 Jul; 184():109668. PubMed ID: 37030399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Having ypN0 may not be enough to abandon the Postmastectomy Radiotherapy (PMRT) in Her-2 positive patients.
    Fayda M
    Radiother Oncol; 2023 Aug; 185():109722. PubMed ID: 37244359
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
    Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
    [No Abstract]   [Full Text] [Related]  

  • 5. Locoregional and Distant Outcomes in Women With cT1-3N1 Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Adjuvant Radiotherapy.
    Kozak MM; von Eyben R; Gutkin PM; Vemuri M; Jacobson CE; Karl JJ; Walck E; Marquez C; Horst KC
    Clin Breast Cancer; 2021 Aug; 21(4):373-382. PubMed ID: 33766533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.
    Fowble B; Jairam AK; Wang F; Peled A; Alvarado M; Ewing C; Esserman L; Park C; Lazar A
    Clin Breast Cancer; 2018 Feb; 18(1):e107-e113. PubMed ID: 28830795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
    Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
    Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis.
    Zhang J; Lu CY; Chen CH; Chen HM; Wu SY
    Breast; 2020 Dec; 54():70-78. PubMed ID: 32947148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy.
    Kim D; Kim JH; Kim IA; Chang JH; Shin KH
    Cancer Res Treat; 2023 Apr; 55(2):592-602. PubMed ID: 36228653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of postmastectomy radiation therapy in clinically node-positive breast cancerpatients with pathologically negative lymph nodes after neoadjuvant chemotherapy.
    Sayan M; Vergalasova I; George M; Kowzun M; Potdevin L; Kumar S; Haffty B; Ohri N
    Turk J Med Sci; 2022 Apr; 52(2):279-285. PubMed ID: 36161617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.
    McBride A; Allen P; Woodward W; Kim M; Kuerer HM; Drinka EK; Sahin A; Strom EA; Buzdar A; Valero V; Hortobagyi GN; Hunt KK; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):392-8. PubMed ID: 24721590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
    Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
    Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1-3 positive lymph nodes: a retrospective study.
    Chitapanarux I; Tharavichitkul E; Jakrabhandu S; Klunklin P; Onchan W; Srikawin J; Pukanhaphan N; Traisathit P; Vongtama R
    J Radiat Res; 2014 Jan; 55(1):121-8. PubMed ID: 23788495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.
    Hehr T; Baumann R; Budach W; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Krug D; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
    Strahlenther Onkol; 2019 Nov; 195(11):949-963. PubMed ID: 31451835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
    Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy.
    Gilmore RC; Sebai ME; Psoter KJ; Prasath V; Siotos C; Broderick KP; Jacobs LK; Harvey SC; Habibi M
    Sci Rep; 2020 Jun; 10(1):9887. PubMed ID: 32555240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mastectomy radiation therapy in breast cancer patients with 1-3 positive lymph nodes: No one size fits all.
    Kayali M; Abi Jaoude J; Tfayli A; El Saghir N; Poortmans P; Zeidan YH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102880. PubMed ID: 32045847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.